Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma

Leukemia & Lymphoma
W MillsD C Linch

Abstract

We have previously demonstrated a dose response relationship in Hodgkin's disease for the combination of BCNU, VP16, Ara C and Melphalan, with the superior efficacy of the BEAM regimen requiring haemopoietic support, compared with miniBEAM. To further exploit this, we have attempted to escalate the VP16 dose in BEAM. The standard etoposide dose is 200 mg/m2 IV for four days. Thirty seven patients with refractory lymphoma received 400 mg/m2/day of etoposide, and 13 patients 600 mg/m2/day, in addition to BCNU, cytarabine, and melphalan. Toxicity and outcome parameters were compared in the preceding 40 patients, who received 200 mg/m2/day etoposide. The toxic mortality with 400 mg/m2/day of etoposide (3%) was identical to that for the standard BEAM regimen (5%). Two procedure related deaths occurred in the highest VP16 dose group (15%). The morbidity of the lower etoposide dose regimens was comparable, but 600 mg/m2/day induced significantly greater gastrointestinal toxicity. Twelve of the 13 patients receiving this dose suffered grade II-IV mucositis, with stomatitis, dysphagia and prolonged diarrhoea; 5 haemodynamically significant gastrointestinal haemorrhage, and 1 fatal toxic colitis. Granulocyte colony stimulating factor did...Continue Reading

References

Nov 19, 1992·The New England Journal of Medicine·G P CanellosB A Peterson
Jan 1, 1990·Leukemia Research·A H Goldstone, A Khwaja
Jan 1, 1990·Pediatric Hematology and Oncology·C M MandigersA G Theeuwes
Jan 1, 1990·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S VivianiG Bonadonna
Feb 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Oct 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G L PhillipsD E Reece
Feb 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M Vose, J O Armitage
Mar 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J JonesS D Rowley
Apr 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F B PetersenR Storb
Apr 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C WheelerL E Schnipper
May 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S FreedmanL Heflin
Feb 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S JagannathF B Hagemeister
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J G GribbenJ D Richards
Oct 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S I BearmanE D Thomas
Jul 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T PhilipF Chauvin
Sep 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Dec 1, 1970·Annals of Internal Medicine·V T DevitaP P Carbone
Feb 1, 1982·Annals of Internal Medicine·A SantoroG Bonadonna
Jul 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N TannirF Cabanillas
Apr 8, 1993·The New England Journal of Medicine·J O Armitage

❮ Previous
Next ❯

Citations

Dec 22, 1999·British Journal of Haematology·D C Linch, A H Goldstone
Jun 29, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·H Miles PrinceDavid Belford
Nov 16, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Gordon L PhillipsJonathan W Friedberg
Apr 27, 2004·Cancer·Stephen T SonisUNKNOWN International Society for Oral Oncology
Apr 15, 2011·The Cochrane Database of Systematic Reviews·Helen V WorthingtonTasneem Khalid

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

© 2021 Meta ULC. All rights reserved